British Patient Capital

Private equity and venture capital produce the highest returns on average when comparing asset classes but the top performing venture capital funds can generate higher gains. Download British Business Bank's report to find out more here: https://bit.ly/3WCYtUh #VentureCapital #VC

13books Capital's latest fund will back the new wave of innovative fintech businesses supporting tructural transformation of the industry as it becomes more and more digitised. The UK is home to many leading fintech businesses, including a number of unicorns. As investors in tomorrow’s financial technology. As an investor in tomorrow's technology, we're pleased to have committed £25m to the fund. Our MD Christine Hockley said: "The team at 13books Capital has the experience and sectoral expertise required to back bold founders and support early-stage fintech businesses as they look to scale."

#ICYMI: British Business Bank's #EquityTracker24 shows the UK is the third largest VC market globally 💪 Read the full report here: https://lnkd.in/d4pYBSC8

#FridayRead British Business Bank's #EquityTracker24 shows that 62% of UK unicorns have received equity finance or support from the Bank's programme 🦄 We're pleased to have played a role in this, supporting innovative high growth companies to help them become the success stories of tomorrow. Read the full report for the full picture of the small business equity market: https://bit.ly/4cUJhH4

We've committed £25m to 13books Capital's latest fund. The fund will back the new wave of innovative fintech businesses supporting structural transformation of the industry as it becomes more and more digitised. Read more here: https://bit.ly/3zM79i8

The latest Small Business Equity Tracker from British Business Bank shows the UK is now the third largest VC market in the world 💪 Our MD Christine Hockley shares her insights on the opportunities in deeptech and lifesciences.

Patient capital plays an essential role in fuelling innovation and progress for life sciences and deeptech, says our MD Christine Hockley, commenting on the findings of British Business Bank’s #EquityTracker24 report. Read the full comment here: https://bit.ly/3zFAJpp

“In the UK we’re good at starting companies but not so good at scaling them up. We would like to see more home-grown, fully-funded champions.” Our Board Director Ian Connatty spoke to ICAS - The Professional Body of CAs magazine about our mission to support high-growth companies with patient capital and put a spotlight on the inspiring success stories in our portfolio.

📣 Meet our new board • Louis Taylor, CEO of British Business Bank, has also been appointed as Chair of British Patient Capital • Ian Connatty, the Bank’s Deputy Chief Investment Officer, joins the board as a Director, alongside Hazel Moore, Non-executive Director Louis takes over from Russ Cummings, who has stepped down after six years on the board, which he joined when British Patient Capital was established in 2018. Tom Haywood, CFA has been appointed as Managing Director, Direct Investments. Tom joined British Patient Capital in 2019 and he helped set up its direct investment function. Read more here: https://lnkd.in/d_zaMntn

We've invested in Myricx Bio's £90m Series A round via Future Fund: Breakthrough. Myricx Bio are developing a new platform for targeted cancer therapy. The investment will help them build their platform and advance their clinical trials. Read more: https://bit.ly/3WaBSy0